Undisclosed Lead Program(s)

About NemaGen Discoveries

NemaGen Discoveries is a private, pre-clinical stage biotechnology company pioneering therapeutic strategies derived from the study of parasitic immunology. Its core platform investigates the body's natural regulatory mechanisms following parasitic infection to develop novel treatments for mast cell-driven inflammatory disorders. The company is currently in the early research and development phase, positioning itself to address significant unmet needs in allergy and inflammation. As a private entity, it operates pre-revenue and is likely funded by grants and early-stage venture capital.

About Entelexo Biotherapeutics

Entelexo Biotherapeutics is a private, pre-clinical stage biotech leveraging engineered exosomes to treat complex autoimmune diseases. Its core innovation is a rational engineering platform that designs exosomes to deliver targeted messages to multiple diseased cell types at once, moving beyond single-pathway blockade. The company has built an initial pipeline, de-risked candidates in human cell assays, and is progressing toward IND-enabling studies, having secured pre-seed funding and notable accelerator support.

Therapeutic Areas